Developing an AI model to assess the quality of oocytes.
CHLOE Oocyte Data Collection Protocol
Fairtility · NCT06928337
This study is testing a new app that uses artificial intelligence to help doctors check the quality of eggs used in fertility treatments to see if it can make their work easier and more accurate.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 350 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Fairtility (industry) |
| Locations | 1 site (Scottsdale, Arizona) |
| Trial ID | NCT06928337 on ClinicalTrials.gov |
What this trial studies
This protocol focuses on collecting data to develop the CHLOE-OQ application, which uses artificial intelligence to evaluate oocyte quality. It encompasses the entire lifecycle of AI model development, including training, verification, and validation to ensure accuracy and effectiveness. The study also includes simulated use assessments to evaluate the usability and functionality of the CHLOE applications in clinical settings, ensuring they are user-friendly for embryologists. By continuously refining the model with new data, the CHLOE application aims to enhance its performance over time.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older who have embryos or eggs cultured in a time-lapse incubator connected to the CHLOE Embryo Viewer.
Not a fit: Women with autologous eggs may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved assessment of oocyte quality, enhancing fertility treatment outcomes for patients.
How similar studies have performed: Other studies utilizing AI for fertility assessments have shown promise, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women at least 18 years of age. * Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer. Exclusion Criteria: * Women with autologous eggs
Where this trial is running
Scottsdale, Arizona
- The World Egg and Sperm Bank — Scottsdale, Arizona, United States (RECRUITING)
Study contacts
- Study coordinator: Pedro Pini, M.D
- Email: pedro.pini@fairtility.com
- Phone: +54 9 1144704026
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Fertility Disorders